NEULANDLAB.NS
Neuland Laboratories Ltd
Price:
12,474
INR
Volume:
24,235
India | Pharmaceuticals
Discounted Cash Flow
Trading Multiples
Peter Lynch Fair Value
Earnings Power Value
Dividend Discount Model
WACC
NEULANDLAB.NS Intrinsic Value
-75.3 %
Upside
What is the intrinsic value of NEULANDLAB.NS?
As of 2025-05-15, the Intrinsic Value of Neuland Laboratories Ltd (NEULANDLAB.NS) is 3,079.03 INR. This NEULANDLAB.NS valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 12,474 INR, the upside of Neuland Laboratories Ltd is -75.3%.
The range of the Intrinsic Value is 2,588.06 - 3,828.09 INR.
Is NEULANDLAB.NS undervalued or overvalued?
Based on its market price of 12,474 INR and our intrinsic valuation, Neuland Laboratories Ltd (NEULANDLAB.NS) is overvalued by 75.3%.
12,474 INR
Stock Price
3,079.03 INR
Intrinsic Value
| Range | Selected | Upside | ||
| a | ||||
| DCF (Growth Exit 5Y) | 2,588.06 - 3,828.09 | 3,079.03 | -75.3% | |
| DCF (Growth Exit 10Y) | 4,080.94 - 6,021.75 | 4,855.39 | -61.1% | |
| DCF (EBITDA Exit 5Y) | 9,414.42 - 11,263.07 | 10,245.73 | -17.9% | |
| DCF (EBITDA Exit 10Y) | 9,613.9 - 12,727.27 | 11,001.01 | -11.8% | |
| Peter Lynch Fair Value | 5,843.03 - 5,843.03 | 5,843.03 | -53.16% | |
| P/E Multiples | 6,548.86 - 8,298.65 | 7,221.97 | -42.1% | |
| EV/EBITDA Multiples | 4,764.3 - 7,186.27 | 5,830.63 | -53.3% | |
| Earnings Power Value | 778.85 - 949.29 | 864.07 | -93.1% | |
| Dividend Discount Model - Stable | 1,101.71 - 2,168.92 | 1,635.31 | -86.9% | |
| Dividend Discount Model - Multi Stages | 2,715.61 - 4,171.46 | 3,291.08 | -73.6% | |
| Market Cap (mil) | 160,041 |
| Beta | 1.21 |
| Outstanding shares (mil) | 13 |
| Enterprise Value (mil) | 160,266 |
| Market risk premium | 8.8% |
| Cost of Equity | 16.3% |
| Cost of Debt | 7.65% |
| WACC | 16.2% |